Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis
NCT03560557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116
Last updated 2021-01-22
Summary
WP1.1. PK/PD target attainment: Plasma exposure, Excretion via urine \& ELF exposure; WP1.2. Predictive dosing algorithm; WP1.3. ECMO subset
Conditions
- Critical Illness
- Pharmacokinetics
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Isabel Spriet, PharmD PhD · UZ Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
More Related Trials
-
Imipenem/Cilastatin/Relebactam PK in ECMO
NCT04493151 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department
NCT02365272 ·Status: COMPLETED ·Phase: PHASE4
-
Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics
NCT04571801 ·Status: COMPLETED ·Phase: NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
NCT05975671 ·Status: RECRUITING ·Phase: NA
-
Monitoring Resuscitation in Severe Sepsis and Septic Shock
NCT01747057 ·Status: UNKNOWN ·Phase: NA
-
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033 ·Status: UNKNOWN
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Lactate Clearance According to the Presence of Hepatic Dysfunction
NCT01709565 ·Status: UNKNOWN
-
A Pharmacokinetics Study of Meropenem and Piperacillin in Patients With Sepsis
NCT05807217 ·Status: UNKNOWN
-
Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients
NCT01027897 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO)
NCT03131063 ·Status: COMPLETED
-
Meropenem and Ciprofloxacin Dosing in Septic Shock
NCT02240277 ·Status: UNKNOWN
-
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
NCT03344627 ·Status: COMPLETED ·Phase: NA
-
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781 ·Status: COMPLETED
-
Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU
NCT05367011 ·Status: NOT_YET_RECRUITING
-
Sepsis Pre-Alert Monitoring Intervention: Study to Investigate Targeted Enhanced Monitoring for Sepsis
NCT03473769 ·Status: WITHDRAWN ·Phase: NA
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
Population Pharmacokinetics of Anti-infectives in Critically Ill Children
NCT02539407 ·Status: RECRUITING
-
Pharmacokinetic of Ceftriaxone in Septic ICU Patients
NCT00449800 ·Status: UNKNOWN ·Phase: PHASE4
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
NCT05824767 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock
NCT01473498 ·Status: TERMINATED ·Phase: NA
-
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission
NCT03601767 ·Status: UNKNOWN
-
EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS
NCT07122596 ·Status: COMPLETED ·Phase: PHASE4